|
Feb 24
|
Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™
|
|
Feb 23
|
We're Not Worried About Glaukos' (NYSE:GKOS) Cash Burn
|
|
Feb 22
|
Wingstop Stock’s Dip Is an Opportunity, Analyst Says. Plus, Devon Energy, Cadence Design, and More.
|
|
Feb 21
|
GKOS Stock Falls Despite Q4 Earnings & Revenue Beat, Margins Decline
|
|
Feb 21
|
Glaukos Corp (GKOS) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Growth Amid ...
|
|
Feb 20
|
Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 20
|
Glaukos: Q4 Earnings Snapshot
|
|
Feb 20
|
Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results
|
|
Feb 20
|
Apple unveils iPhone 16e, Arista reports Q4 beat: Morning Buzz
|
|
Feb 19
|
What to Expect From These 3 MedTech Stocks This Earnings Season?
|
|
Feb 17
|
What Analyst Projections for Key Metrics Reveal About Glaukos (GKOS) Q4 Earnings
|
|
Jan 15
|
GKOS Stock Gains Following Positive Study Data on iDose Platform
|
|
Jan 14
|
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
|
|
Jan 4
|
Glaukos price target raised to $157 from $149 at BTIG
|
|
Oct 17
|
GKOS Stock Rises on Positive Phase 3 Confirmatory Trial for Epioxa
|
|
Oct 17
|
Glaukos eyes FDA approval for ocular therapy after Phase III win
|
|
Oct 16
|
Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety
|
|
Oct 14
|
Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting
|
|
Jul 30
|
Will These 4 MedTech Stocks Beat Forecasts This Earnings Season?
|
|
Jul 30
|
A Look At The Fair Value Of Glaukos Corporation (NYSE:GKOS)
|